Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
NANot yet recruitingINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
October 31, 2025
Primary Completion Date
November 30, 2025
Study Completion Date
March 31, 2026
Conditions
WrinkleScarLaxity; Skin
Interventions
DEVICE
Karisma
Intradermal injection
All Listed Sponsors
collaborator
Nextrasearch S.r.l.s.
OTHER
lead
Taumedika s.r.l.
INDUSTRY
NCT06336044 - Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen' | Biotech Hunter | Biotech Hunter